Artrya (ASX:AYA) is set to raise AU$5 million via the placing of around 11.9 million shares at AU$0.42 apiece, according to a Tuesday filing with the Australian bourse.
Proceeds will support the commercialization of the company's Salix Coronary Anatomy platform for detecting coronary artery disease imaging markers, the filing said.
Petra Capital acted as sole lead manager and sole bookrunner to the placement.
Artrya's shares were down 6% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.